doi.org/10.1016/s1473-3099(20)30770-2

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

..., Kyla Comins
5
The Lancet Infectious Diseases31.00
Volume: 21, Issue: 7, Pages: 975 - 983
Published: Feb 15, 2021
Paper Fields
Paper Details
Title
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial
DOI
doi.org/10.1016/s1473-3099(20)30770-2
Published Date
Feb 15, 2021
Journal
The Lancet Infectious Diseases
Volume
21
Issue
7
Pages
975 - 983
© 2025 Pluto Labs All rights reserved.